SCHEMBL21946750

SCHEMBL21946750

NC(=O)c1ncc(N2CCCCC2)nc1Nc1cc2n(n1)CCNC2

nearest known ligand 0.40

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ BTK Q06187 14/20 0.40
▸ JAK3 P52333 13/20 0.40
▸ LCK P06239 12/20 0.40
▸ EGFR P00533 6/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21946915 0.83 LCK (0.46) BTKJAK3LCKEGFR
SCHEMBL31039918 0.82 JAK3 (0.65) BTKJAK3LCKEGFR
SCHEMBL21855290 0.82 JAK3 (0.65) BTKJAK3LCKEGFR
SCHEMBL23484809 0.82 CHRNB2 (0.39) BTKJAK3
SCHEMBL21946745 0.77 CDK4 (0.49) BTKJAK3LCKEGFR
SCHEMBL25595883 0.74 SYK (0.50) BTKJAK3LCKEGFR
SCHEMBL24891043 0.74 LCK (0.47) BTKJAK3LCKEGFR
SCHEMBL21946319 0.74 BTK (0.59) BTKJAK3LCKEGFR
SCHEMBL21855202 0.74 BTK (0.59) BTKJAK3LCKEGFR
SCHEMBL25593539 0.73 BTK (0.49) BTKJAK3LCKEGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020081450-A1 BIFUNCTIONAL COMPOUNDS FOR DEGRADING BTK VIA UBIQUITIN PROTEOSOME PATHWAY NURIX THERAPEUTICS, INC. (US) 2020-04-23 — — WO disclosed
Send feedback